Clinical Trial Update: Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

View source ↗

Summary

This clinical trial, conducted by Hebei Medical University Fourth Hospital, aims to develop and evaluate a multi-omics-based early warning system for tumor immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Malignant Neoplasm, Organ Damage | Status: RECRUITING